Poland· PL-100046855
Neoton
A fosfocreatin product containing phosphocreatini natricum, registered in Poland by Alfasigma Polska Sp. z o.o.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Fosfocreatin is registered in 2 of 19 countries.
Countries holding a registration under ATC C01EB06 (fosfocreatin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Fosfocreatin · ATC C01EB06
2 / 19 countries
- Czechiaprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Phosphocreatini natricum
- Manufacturer
- Alfasigma Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- C01EB06
- ATC class
- Fosfocreatin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990278619
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fosfocreatin in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Czechia · Neoton Phlebo
- Italy · Seldomalfa
- Romania · Neoton
- Slovakia · Neoton
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f1532bae-9027-4da9-a77b-28703538549c GET /v1/drugs/f1532bae-9027-4da9-a77b-28703538549c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "1 g",
"packaging": "05909990278619 ¦ Lz ¦ 62744\n1 fiol. proszku ¦ 1 butelka 50 ml rozp. ¦ 1 zestaw do podawania",
"substance": "Phosphocreatinum natricum 1000 mg",
"common_name": "Phosphocreatini natricum",
"pl_product_id": "100046855",
"pozwolenie_nr": "02786",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about fosfocreatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.